Borongosam, Binasing M.
HRN: 16-92-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/17/2024
10/23/2024
IV
2.25G
TID
CAPMR, SKIN INFECTION
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft TissueMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes